Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
How Retatrutide Compares to Existing Therapies The progression from single to dual to triple agonist therapy represents a clear trend in obesity pharmacotherapy: Semaglutide (GLP-1 agonist): ~1517% weight loss in Phase III (STEP trials) Tirzepatide (GIP + GLP-1 dual agonist): ~2022.5% weight loss in Phase III (SURMOUNT trials) Retatrutide (GIP + GLP-1 + glucagon triple agonist): ~2629% weight loss in Phase III (TRIUMPH-4) Each additional receptor pathway appears to contribute incremental efficacy
Wegovy is specifically approved for weight management, while Ozempic is licensed to help manage type 2 diabetes
Horarios recomendados para tomar GLP-1: maana vs noche Factores que influyen en el mejor momento para tomar GLP-1 Efectos secundarios segn el horario de administracin Recomendaciones mdicas para optimizar el tratamiento con GLP-1 Preguntas Frecuentes Qu son los medicamentos GLP-1 y cmo funcionan
Protein is the priority Protein intake preservation is the single most important dietary focus during tirzepatide treatment
